XML 53 R43.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue - Business Revenue (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 26, 2022
Mar. 27, 2021
Mar. 26, 2022
Mar. 27, 2021
Disaggregation of Revenue [Line Items]        
Revenues $ 1,435.7 $ 1,537.6 $ 2,906.9 $ 3,147.4
Contract with Customer, Liability, Revenue Recognized 30.9 30.1 87.3 80.8
United States        
Disaggregation of Revenue [Line Items]        
Revenues 992.4 1,064.0 2,004.8 2,201.7
International        
Disaggregation of Revenue [Line Items]        
Revenues 443.3 473.6 902.1 945.7
Diagnostics        
Disaggregation of Revenue [Line Items]        
Revenues 987.1 1,064.5 1,937.5 2,192.7
Diagnostics | United States        
Disaggregation of Revenue [Line Items]        
Revenues 645.1 705.2 1,260.4 1,468.6
Diagnostics | International        
Disaggregation of Revenue [Line Items]        
Revenues 342.0 359.3 677.1 724.1
Diagnostics | Cytology & Perinatal        
Disaggregation of Revenue [Line Items]        
Revenues 115.4 117.2 245.9 242.0
Diagnostics | Cytology & Perinatal | United States        
Disaggregation of Revenue [Line Items]        
Revenues 72.1 76.8 153.0 156.9
Diagnostics | Cytology & Perinatal | International        
Disaggregation of Revenue [Line Items]        
Revenues 43.3 40.4 92.9 85.1
Diagnostics | Molecular Diagnostics        
Disaggregation of Revenue [Line Items]        
Revenues 862.5 935.3 1,676.0 1,930.6
Diagnostics | Molecular Diagnostics | United States        
Disaggregation of Revenue [Line Items]        
Revenues 563.8 616.4 1,091.8 1,291.6
Diagnostics | Molecular Diagnostics | International        
Disaggregation of Revenue [Line Items]        
Revenues 298.7 318.9 584.2 639.0
Diagnostics | Blood Screening        
Disaggregation of Revenue [Line Items]        
Revenues 9.2 12.0 15.6 20.1
Diagnostics | Blood Screening | United States        
Disaggregation of Revenue [Line Items]        
Revenues 9.2 12.0 15.6 20.1
Diagnostics | Blood Screening | International        
Disaggregation of Revenue [Line Items]        
Revenues 0.0 0.0 0.0 0.0
Breast Health        
Disaggregation of Revenue [Line Items]        
Revenues 310.4 336.3 669.9 669.1
Breast Health | United States        
Disaggregation of Revenue [Line Items]        
Revenues 239.5 253.0 510.6 511.2
Breast Health | International        
Disaggregation of Revenue [Line Items]        
Revenues 70.9 83.3 159.3 157.9
Breast Health | Breast Imaging        
Disaggregation of Revenue [Line Items]        
Revenues 245.0 269.9 527.3 537.6
Breast Health | Breast Imaging | United States        
Disaggregation of Revenue [Line Items]        
Revenues 187.4 198.1 396.3 401.1
Breast Health | Breast Imaging | International        
Disaggregation of Revenue [Line Items]        
Revenues 57.6 71.8 131.0 136.5
Breast Health | Interventional Breast Solutions        
Disaggregation of Revenue [Line Items]        
Revenues 65.4 66.4 142.6 131.5
Breast Health | Interventional Breast Solutions | United States        
Disaggregation of Revenue [Line Items]        
Revenues 52.1 54.9 114.3 110.1
Breast Health | Interventional Breast Solutions | International        
Disaggregation of Revenue [Line Items]        
Revenues 13.3 11.5 28.3 21.4
GYN Surgical        
Disaggregation of Revenue [Line Items]        
Revenues 117.3 114.2 251.6 238.2
GYN Surgical | United States        
Disaggregation of Revenue [Line Items]        
Revenues 94.0 91.7 203.3 192.8
GYN Surgical | International        
Disaggregation of Revenue [Line Items]        
Revenues 23.3 22.5 48.3 45.4
Skeletal Health        
Disaggregation of Revenue [Line Items]        
Revenues 20.9 22.6 47.9 47.4
Skeletal Health | United States        
Disaggregation of Revenue [Line Items]        
Revenues 13.8 14.1 30.5 29.1
Skeletal Health | International        
Disaggregation of Revenue [Line Items]        
Revenues $ 7.1 $ 8.5 $ 17.4 $ 18.3